Abstract
Vincristine sulfate, a useful agent in treatment of childhood leukemia, lymphoma, and a great variety of solid tumors, is a potentially serious neurotoxin. A mixed sensory-motor neuropathy is the most common manifestation of drug toxicity, but other effects have been attributed to this drug, including seizures, mental changes, orthostatic hypotension, inappropriate secretion of antidiuretic hormone, and potentiation of preexisting neurological disease. A critical review of published data does not confirm a causal relation between vincristine administration and these neurotoxic effects. Only in the cases of hyponatremia that are secondary to inappropriate secretion of antidiuretic hormone has a convincing causal relation been established.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
